4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000039
Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 36,877 | D |
| 2026-05-15 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 40,377 | D |
| 2026-05-15 | Sale : show line 3 in the form 10b5-1 | −4,800 | $61.56 | $295,495 | 35,577 | D |
| 2026-05-15 | Sale : show line 4 in the form 10b5-1 | −2,100 | $62.42 | $131,088 | 33,477 | D |
| 2026-05-15 | Sale : show line 5 in the form 10b5-1 | −100 | $63.52 | $6,352 | 33,377 | D |
| Open-market sales · 7,000 sh · avg $61.85 · $432,935 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-15 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 207,563 | D |
| 2026-05-15 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 178,992 | D |
Loading xslF345X06/form4.xml…